Literature DB >> 26829187

Bridging the Gap Between Science and Clinical Efficacy: Physiology, Imaging, and Modeling of Aerosols in the Lung.

Chantal Darquenne1, John S Fleming2,3, Ira Katz4,5, Andrew R Martin6, Jeffry Schroeter7, Omar S Usmani8, Jose Venegas9, Otmar Schmid10,11.   

Abstract

Development of a new drug for the treatment of lung disease is a complex and time consuming process involving numerous disciplines of basic and applied sciences. During the 2015 Congress of the International Society for Aerosols in Medicine, a group of experts including aerosol scientists, physiologists, modelers, imagers, and clinicians participated in a workshop aiming at bridging the gap between basic research and clinical efficacy of inhaled drugs. This publication summarizes the current consensus on the topic. It begins with a short description of basic concepts of aerosol transport and a discussion on targeting strategies of inhaled aerosols to the lungs. It is followed by a description of both computational and biological lung models, and the use of imaging techniques to determine aerosol deposition distribution (ADD) in the lung. Finally, the importance of ADD to clinical efficacy is discussed. Several gaps were identified between basic science and clinical efficacy. One gap between scientific research aimed at predicting, controlling, and measuring ADD and the clinical use of inhaled aerosols is the considerable challenge of obtaining, in a single study, accurate information describing the optimal lung regions to be targeted, the effectiveness of targeting determined from ADD, and some measure of the drug's effectiveness. Other identified gaps were the language and methodology barriers that exist among disciplines, along with the significant regulatory hurdles that need to be overcome for novel drugs and/or therapies to reach the marketplace and benefit the patient. Despite these gaps, much progress has been made in recent years to improve clinical efficacy of inhaled drugs. Also, the recent efforts by many funding agencies and industry to support multidisciplinary networks including basic science researchers, R&D scientists, and clinicians will go a long way to further reduce the gap between science and clinical efficacy.

Entities:  

Keywords:  PET; SPECT; aerosol deposition distribution; biological lung models; in-silico lung modeling

Mesh:

Substances:

Year:  2016        PMID: 26829187      PMCID: PMC4841911          DOI: 10.1089/jamp.2015.1270

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  123 in total

Review 1.  Aerosol deposition in health and disease.

Authors:  Chantal Darquenne
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2012-06       Impact factor: 2.849

2.  CFD simulation of aerosol deposition in an anatomically based human large-medium airway model.

Authors:  Baoshun Ma; Kenneth R Lutchen
Journal:  Ann Biomed Eng       Date:  2008-12-12       Impact factor: 3.934

3.  Standardization of techniques for using single-photon emission computed tomography (SPECT) for aerosol deposition assessment of orally inhaled products.

Authors:  John Fleming; Dale L Bailey; Hak-Kim Chan; Joy Conway; Philip J Kuehl; Beth L Laube; Stephen Newman
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2012-12       Impact factor: 2.849

4.  Targeting aerosol deposition in patients with cystic fibrosis: effects of alterations in particle size and inspiratory flow rate.

Authors:  B L Laube; R Jashnani; R N Dalby; P L Zeitlin
Journal:  Chest       Date:  2000-10       Impact factor: 9.410

5.  Feasibility and safety of targeted cisplatin delivery to a select lung lobe in dogs via the AeroProbe intracorporeal nebulization catheter.

Authors:  Kim Selting; J Clifford Waldrep; Carol Reinero; Keith Branson; Daniel Gustafson; Dae Young Kim; Carolyn Henry; Nellie Owen; Richard Madsen; Rajiv Dhand
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2008-09       Impact factor: 2.849

6.  Standardization of techniques for using planar (2D) imaging for aerosol deposition assessment of orally inhaled products.

Authors:  Stephen Newman; William D Bennett; Martyn Biddiscombe; Sunalene G Devadason; Myrna B Dolovich; John Fleming; Sabine Haeussermann; Claudius Kietzig; Philip J Kuehl; Beth L Laube; Knut Sommerer; Glyn Taylor; Omar S Usmani; Kirby L Zeman
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2012-12       Impact factor: 2.849

Review 7.  Translational models of lung disease.

Authors:  Paul F Mercer; Katharine Abbott-Banner; Ian M Adcock; Richard G Knowles
Journal:  Clin Sci (Lond)       Date:  2015-02       Impact factor: 6.124

Review 8.  Small-airway disease in asthma: pharmacological considerations.

Authors:  Omar S Usmani
Journal:  Curr Opin Pulm Med       Date:  2015-01       Impact factor: 3.155

9.  A dose-controlled system for air-liquid interface cell exposure and application to zinc oxide nanoparticles.

Authors:  Anke Gabriele Lenz; Erwin Karg; Bernd Lentner; Vlad Dittrich; Christina Brandenberger; Barbara Rothen-Rutishauser; Holger Schulz; George A Ferron; Otmar Schmid
Journal:  Part Fibre Toxicol       Date:  2009-12-16       Impact factor: 9.400

10.  Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary disease.

Authors:  J M Hohlfeld; A Sharma; J A van Noord; P J G Cornelissen; E Derom; L Towse; V Peterkin; B Disse
Journal:  J Clin Pharmacol       Date:  2013-11-27       Impact factor: 3.126

View more
  20 in total

1.  Effect of static vs. dynamic imaging on particle transport in CT-based numerical models of human central airways.

Authors:  Shinjiro Miyawaki; Eric A Hoffman; Ching-Long Lin
Journal:  J Aerosol Sci       Date:  2016-07-16       Impact factor: 3.433

2.  Anatomically Based Analysis of Radioaerosol Distribution in Pulmonary Scintigraphy: A Feasibility Study in Asthmatics.

Authors:  Luciana Alcoforado; Armèle Dornelas de Andrade; Joaquin L Herraiz; Simone Cristina Soares Brandão; Jacqueline de Melo Barcelar; James B Fink; Jose G Venegas
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2018-04-19       Impact factor: 2.849

3.  Ventilation/Perfusion Relationships and Gas Exchange: Measurement Approaches.

Authors:  Susan R Hopkins
Journal:  Compr Physiol       Date:  2020-07-08       Impact factor: 9.090

4.  Sufentanil EC50 for endotracheal intubation with aerosol inhalation of carbonated lidocaine by ultrasonic atomizer.

Authors:  Qiaoqiao Xu; Zhiqiang Zhou; Ling Ai; Jieqiong Liu; Xuebi Tian
Journal:  BMC Anesthesiol       Date:  2021-05-12       Impact factor: 2.217

5.  ATTACHED, DETACHED and WITHOUT inhaler technique coaching tools to optimize pMDI use competence, asthma control and quality-of-life in asthmatic adults.

Authors:  Wesam G Ammari; Nathir M Obeidat; Abed Rahman Anani; Reem J AlKalbani; Mark Sanders
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 2.895

Review 6.  New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology.

Authors:  Anthony D D'Urzo; Mario Cazzola; Nicola A Hanania; Roland Buhl; M Reza Maleki-Yazdi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-09-07

7.  Cylindrical Microparticles Composed of Mesoporous Silica Nanoparticles for the Targeted Delivery of a Small Molecule and a Macromolecular Drug to the Lungs: Exemplified with Curcumin and siRNA.

Authors:  Thorben Fischer; Inga Winter; Robert Drumm; Marc Schneider
Journal:  Pharmaceutics       Date:  2021-06-07       Impact factor: 6.321

8.  Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model.

Authors:  Sophie Perinel; Lara Leclerc; Nathalie Prévôt; Agathe Deville; Michèle Cottier; Marc Durand; Jean-Michel Vergnon; Jérémie Pourchez
Journal:  Respir Res       Date:  2016-07-07

9.  Quantitative Imaging of Regional Aerosol Deposition, Lung Ventilation and Morphology by Synchrotron Radiation CT.

Authors:  L Porra; L Dégrugilliers; L Broche; G Albu; S Strengell; H Suhonen; G H Fodor; F Peták; P Suortti; W Habre; A R A Sovijärvi; S Bayat
Journal:  Sci Rep       Date:  2018-02-23       Impact factor: 4.379

Review 10.  Is there room for further innovation in inhaled therapy for airways disease?

Authors:  Martyn F Biddiscombe; Omar S Usmani
Journal:  Breathe (Sheff)       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.